News
INmune Bio Inc. Presents Data On INB03's Role As An Immune Check Point Modulator In The Treatment Of High-Risk Breast Cancer At AACR 2024
8 Apr 24
Biotech, News, General
INmune Bio: Q4 Earnings Insights
28 Mar 24
Earnings
INmune Bio Q4 EPS $(0.47) Misses $(0.44) Estimate, Sales $28.00K Miss $40.00K Estimate
28 Mar 24
Earnings, News
Earnings Scheduled For March 28, 2024
28 Mar 24
Earnings
A Preview Of INmune Bio's Earnings
27 Mar 24
Earnings
INmune Bio Reports Significant EEG Improvement In Alzheimer's Patients Treated With XPro
5 Mar 24
Biotech, News, General